Literature DB >> 26792177

Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer.

Nadia Nathan1, Violaine Giraud2, Clément Picard3, Hilario Nunes4, Florence Dastot-Le Moal5, Bruno Copin5, Laurie Galeron6, Alice De Ligniville6, Nathalie Kuziner6, Martine Reynaud-Gaubert7, Dominique Valeyre4, Louis-Jean Couderc3, Thierry Chinet2, Raphaël Borie8, Bruno Crestani8, Maud Simansour9, Valérie Nau5, Sylvie Tissier5, Philippe Duquesnoy9, Lamisse Mansour-Hendili5, Marie Legendre10, Caroline Kannengiesser11, Aurore Coulomb-L'Hermine12, Laurent Gouya13, Serge Amselem14, Annick Clement1.   

Abstract

Idiopathic interstitial pneumonias (IIPs) comprise a heterogeneous group of rare lung parenchyma disorders with high morbidity and mortality, which can occur at all ages. In adults, the most common form of IIPs, idiopathic pulmonary fibrosis (IPF), has been associated with an increased frequency of lung cancer. The molecular basis of IIPs remains unknown in most cases. This study investigates IIP pathophysiology in 12 families affected by IPF and lung cancer. We identified, in a multigenerational family, nine members carrying a heterozygous missense mutation with evidence of pathogenicity in SFTPA1 that encodes the surfactant protein (SP)-A1. The mutation (p.Trp211Arg), which segregates with a disease phenotype characterized by either isolated IIP/IPF, or IPF associated with lung adenocarcinoma, is located in the carbohydrate recognition domain (CRD) of SP-A1 and involves a residue invariant throughout evolution, not only in SP-A1, but also in its close paralog SP-A2 and other CRD-containing proteins. As shown through functional studies, the p.Trp211Arg mutation impairs SP-A1 secretion. Immunohistochemistry studies on patient alveolar epithelium showed an altered SP-A expression pattern. Overall, this first report of a germline molecular defect in SFTPA1 unveils the key role of SP-A1 in the occurrence of several chronic respiratory diseases, ranging from severe respiratory insufficiency occurring early in life to the association of lung fibrosis and cancer in adult patients. These data also clearly show that, in spite of their structural and functional similarities, SP-A1 and SP-A2 are not redundant.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26792177     DOI: 10.1093/hmg/ddw014

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

Review 1.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  Recent progress on surfactant protein A: cellular function in lung and kidney disease development.

Authors:  Skylar D King; Shi-You Chen
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-08       Impact factor: 4.249

3.  The self-fulfilling prophecy of pulmonary fibrosis: a selective inspection of pathological signalling loops.

Authors:  Ashley R Rackow; David J Nagel; Claire McCarthy; Jennifer Judge; Shannon Lacy; Margaret A T Freeberg; Thomas H Thatcher; R Matthew Kottmann; Patricia J Sime
Journal:  Eur Respir J       Date:  2020-11-26       Impact factor: 16.671

Review 4.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 5.  Familial Interstitial Lung Disease.

Authors:  Jonathan A Kropski
Journal:  Semin Respir Crit Care Med       Date:  2020-04-12       Impact factor: 3.119

Review 6.  Insights from human genetic studies of lung and organ fibrosis.

Authors:  Christine Kim Garcia
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 7.  Pulmonary fibrosis in the era of stratified medicine.

Authors:  Susan K Mathai; Chad A Newton; David A Schwartz; Christine Kim Garcia
Journal:  Thorax       Date:  2016-10-31       Impact factor: 9.139

8.  Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.

Authors:  Yoshihiro Hasegawa; Motoko Takahashi; Shigeru Ariki; Atsushi Saito; Yasuaki Uehara; Rina Takamiya; Koji Kuronuma; Hirofumi Chiba; Yuji Sakuma; Hiroki Takahashi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

9.  Familial pulmonary fibrosis: a world without frontiers.

Authors:  Raphael Borie; Bruno Crestani
Journal:  J Bras Pneumol       Date:  2019-10-07       Impact factor: 2.624

10.  Risk factors for the development of idiopathic pulmonary fibrosis: A review.

Authors:  Tanzira Zaman; Joyce S Lee
Journal:  Curr Pulmonol Rep       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.